---
title: Medicare National Coverage Determinations Manual
---

> **Crosswalk to CIM Sections**
>
> Cross references are provided at detailed level only (e.g., at each of
> sections 10.1 through 10.5) as opposed to Section 10. Note that the
> sections are in CPT category sequence and not in Medicare benefit
> category sequence.

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 10        | Anesthesia and Pain Management        | Header          |
+-----------+---------------------------------------+-----------------+
| 10.1      | Use Of Visual Tests Prior To And      | CIM 35-44       |
|           | General Anesthesia During Cataract    |                 |
|           | Surgery                               |                 |
+-----------+---------------------------------------+-----------------+
| 10.2      | Transcutaneous Electrical Nerve       | CIM 45-19       |
|           | Stimulation (TENS) for Acute          |                 |
|           | Post-Operative Pain                   |                 |
+-----------+---------------------------------------+-----------------+
| 10.3      | > Inpatient Hospital Pain             | CIM 35-21       |
|           | > Rehabilitation Programs             |                 |
+-----------+---------------------------------------+-----------------+
| 10.4      | > Outpatient Hospital Pain            | CIM 35-21.1     |
|           | > Rehabilitation Programs             |                 |
+-----------+---------------------------------------+-----------------+
| 10.5      | Autogenous Epidural Blood Graft       | > CIM 45-11     |
+-----------+---------------------------------------+-----------------+
| 10.6      | > Anesthesia in Cardiac Pacemaker     | CIM 35-79       |
|           | > Surgery                             |                 |
+-----------+---------------------------------------+-----------------+
| 20        | Cardiovascular System                 | Header          |
+-----------+---------------------------------------+-----------------+
| 20\. 1    | > Vertebral Artery Surgery            | CIM 35-37       |
+-----------+---------------------------------------+-----------------+
| 20\. 2    | Extracranial-Intracranial (EC-IC)     | CIM 35-37       |
|           | Arterial Bypass Surgery               |                 |
+-----------+---------------------------------------+-----------------+
| 20.3      | Thoracic Duct Drainage (TDD) In Renal | CIM 35-58       |
|           | Transplants                           |                 |
+-----------+---------------------------------------+-----------------+
| 20.4      | > Implantation of Automatic           | CIM 35-85       |
|           | > Defibrillators                      |                 |
+-----------+---------------------------------------+-----------------+
| 20.5      | Extracorporeal Immunoadsorption (ECI) | CIM 35-90       |
|           | Using Protein A Columns               |                 |
+-----------+---------------------------------------+-----------------+
| 20.6      | > Transmyocardial Revascularization   | CIM 35-94       |
|           | > (TMR)                               |                 |
+-----------+---------------------------------------+-----------------+
| 20.7      | > Percutaneous Transluminal           | CIM 50-32       |
|           | > Angioplasty (PTA)                   |                 |
+-----------+---------------------------------------+-----------------+
| 20.8      | > Cardiac Pacemakers                  | CIM 65-6        |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 20.8.1    | > Cardiac Pacemaker Evaluation        | CIM 50-1        |
|           | > Services                            |                 |
+-----------+---------------------------------------+-----------------+
| 20.8.1.1  | Transtelephonic Monitoring of Cardiac | CIM 50-1        |
|           | Pacemakers                            |                 |
+-----------+---------------------------------------+-----------------+
| 20.8.2    | > Self-Contained Pacemaker Monitors   | CIM 60-7        |
+-----------+---------------------------------------+-----------------+
| 20.8.3    | > Anesthesia in Cardiac Pacemaker     | CIM 35-79       |
|           | > Surgery                             |                 |
+-----------+---------------------------------------+-----------------+
| 20.9      | > Artificial Hearts and Related       | CIM 65-16       |
|           | > Devices                             |                 |
+-----------+---------------------------------------+-----------------+
| 20.10     | > Cardiac Rehabilitation Programs     | CIM 35-25       |
+-----------+---------------------------------------+-----------------+
| 20.11     | > Intraoperative Ventricular Mapping  | CIM 35-75       |
+-----------+---------------------------------------+-----------------+
| 20.12     | Diagnostic Endocardial Electrical     | CIM 35-78       |
|           | Stimulation (Pacing)                  |                 |
+-----------+---------------------------------------+-----------------+
| 20.13     | HIS Bundle Study                      | > CIM 50-3      |
+-----------+---------------------------------------+-----------------+
| 20.14     | > Plethysmography                     | CIM 50-6        |
+-----------+---------------------------------------+-----------------+
| 20.15     | > Electrocardiographic Services       | CIM 50-15       |
+-----------+---------------------------------------+-----------------+
| 20.16     | Cardiac Output Monitoring By          | CIM 50-54       |
|           | Electrical Bioimpedance               |                 |
+-----------+---------------------------------------+-----------------+
| 20.17     | > Noninvasive Tests of Carotid        | CIM 50-37       |
|           | > Function                            |                 |
+-----------+---------------------------------------+-----------------+
| 20.18     | Carotid Body Resection/Carotid Body   | CIM 35-7        |
|           | Denervation                           |                 |
+-----------+---------------------------------------+-----------------+
| 20.19     | > Ambulatory Blood Pressure           | CIM 50-42       |
|           | > Monitoring                          |                 |
+-----------+---------------------------------------+-----------------+
| 20.20     | External Counterpulsation (ECP) for   | CIM 35-74       |
|           | Severe Angina                         |                 |
+-----------+---------------------------------------+-----------------+
| 20.21     | Chelation Therapy for Treatment of    | CIM 35-64       |
|           | Atherosclerosis                       |                 |
+-----------+---------------------------------------+-----------------+
| 20.22     | Ethylenediamine-Tetra-Acetic (EDTA)   | CIM 45-20       |
|           | Chelation Therapy for Treatment of    |                 |
|           | Atherosclerosis                       |                 |
+-----------+---------------------------------------+-----------------+
| 20.23     | > Fabric Wrapping of Abdominal        | > CIM 35-34     |
|           | > Aneurysms                           |                 |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 20.24     | > Displacement Cardiography           | > CIM 50-50     |
+-----------+---------------------------------------+-----------------+
| 20.25     | Cardiac Catheterization Performed in  | CIM 35-45       |
|           | Other Than a Hospital Setting         |                 |
+-----------+---------------------------------------+-----------------+
| 20.26     | > Partial Ventriculectomy             | CIM 35-95       |
+-----------+---------------------------------------+-----------------+
| 20.27     | Cardiointegram (CIG) as an            | CIM 50-47       |
|           | Alternative to Stress Test or         |                 |
|           | Thallium Stress Test                  |                 |
+-----------+---------------------------------------+-----------------+
| 20.28     | > Therapeutic Embolization            | CIM 35-35       |
+-----------+---------------------------------------+-----------------+
| 20.29     | Hyperbaric Oxygen Therapy             | CIM 35-10       |
+-----------+---------------------------------------+-----------------+
| 30        | Complementary and Alternative         | Header          |
|           | Medicine                              |                 |
+-----------+---------------------------------------+-----------------+
| 30.1      | Biofeedback Therapy                   | > CIM 35-27     |
+-----------+---------------------------------------+-----------------+
| 30.1.1    | Biofeedback Therapy For The Treatment | CIM 35-27.1     |
|           | Of Urinary Incontinence               |                 |
+-----------+---------------------------------------+-----------------+
| 30.2      | > Thermogenic Therapy                 | > CIM 35-6      |
+-----------+---------------------------------------+-----------------+
| 30.3      | Acupuncture                           | > CIM 35-8      |
+-----------+---------------------------------------+-----------------+
| 30.4      | > Electrosleep Therapy                | CIM 35-18       |
+-----------+---------------------------------------+-----------------+
| 30.5      | > Transcendental Meditation           | CIM 35-92       |
+-----------+---------------------------------------+-----------------+
| 30.6      | > Intravenous Histamine Therapy       | CIM 35-19       |
+-----------+---------------------------------------+-----------------+
| 30.7      | > Laetrile and Related Substances     | CIM 45-10       |
+-----------+---------------------------------------+-----------------+
| 30.8      | > Cellular Therapy                    | CIM 35-5        |
+-----------+---------------------------------------+-----------------+
| 30.9      | Transillumination Light Scanning or   | CIM 50-46       |
|           | Diaphanography                        |                 |
+-----------+---------------------------------------+-----------------+
| 40        | Endocrine System and Metabolism       | Header          |
+-----------+---------------------------------------+-----------------+
| 40.1      | > Diabetes Outpatient Self-Management | CIM 80-2        |
|           | > Training                            |                 |
+-----------+---------------------------------------+-----------------+
| 40.2      | Home Blood Glucose Monitors           | CIM 60-11 and   |
|           |                                       | CIM 60-14       |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 40.3      | Closed-Loop Blood Glucose Control     | CIM 35-70       |
|           | Device (CBGCD)                        |                 |
+-----------+---------------------------------------+-----------------+
| 40.4      | > Insulin Syringe                     | CIM 45-3        |
+-----------+---------------------------------------+-----------------+
| 40.5      | Treatment of Obesity                  | CIM 35-26       |
+-----------+---------------------------------------+-----------------+
| 50        | Ear, Nose and Throat (ENT)            | > Header        |
+-----------+---------------------------------------+-----------------+
| 50.1      | > Speech Generating Devices           | CIM 60-23       |
+-----------+---------------------------------------+-----------------+
| 50.2      | > Electronic Speech Aids              | CIM 65-5        |
+-----------+---------------------------------------+-----------------+
| 50.3      | > Cochlear Implantation               | CIM 65-14       |
+-----------+---------------------------------------+-----------------+
| 50.4      | Tracheostomy Speaking Valve           | CIM 65-165      |
+-----------+---------------------------------------+-----------------+
| 50.5      | Oxygen Treatment of Inner Ear/Carbon  | CIM 35-29       |
|           | Therapy                               |                 |
+-----------+---------------------------------------+-----------------+
| 50.6      | > Tinnitus Masking                    | CIM 35-63       |
+-----------+---------------------------------------+-----------------+
| 50.7      | Cochleostomy with Neurovascular       | CIM 35-50       |
|           | Transplant for Meniere's Disease      |                 |
+-----------+---------------------------------------+-----------------+
| 50.8      | > Ultrasonic Surgery                  | CIM 35-4        |
+-----------+---------------------------------------+-----------------+
| 60        | Emergency Medicine                    | Reserved - no   |
|           |                                       | text            |
+-----------+---------------------------------------+-----------------+
| 70        | Evaluation and Management of Patients | Header          |
|           | (office/hospital/home)                |                 |
+-----------+---------------------------------------+-----------------+
| 70.1      | Consultations With a Beneficiary's    | CIM 35-14       |
|           | Family and Associates                 |                 |
+-----------+---------------------------------------+-----------------+
| 70.2      | Consultation Services Rendered By a   | CIM 50-8        |
|           | Podiatrist in a Skilled Nursing       |                 |
|           | Facility                              |                 |
+-----------+---------------------------------------+-----------------+
| 70.2.1    | Services Provided for the Diagnosis   | CIM 50.8.1      |
|           | and Treatment of Diabetic Sensory     |                 |
|           | Neuropathy with Loss of Protective    |                 |
|           | Sensation (aka Diabetic Peripheral    |                 |
|           | Neuropathy)                           |                 |
+-----------+---------------------------------------+-----------------+
| 70.3      | Physician's Office Within an          | CIM 45-15       |
|           | Institution -- Coverage of Services   |                 |
|           | and Supplies Incident to a            |                 |
|           | Physician's Services                  |                 |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 70.4      | Pronouncement of Death                | > CIM 50-19     |
+-----------+---------------------------------------+-----------------+
| 70.5      | Hospital and Skilled Nursing Facility | CIM 50-28       |
|           | Admission Diagnostic Procedures       |                 |
+-----------+---------------------------------------+-----------------+
| 80        | Eye                                   | > Header        |
+-----------+---------------------------------------+-----------------+
| 80.1      | Hydrophilic Contact Lens for Corneal  | > CIM 45-7      |
|           | Bandage                               |                 |
+-----------+---------------------------------------+-----------------+
| 80.2      | Photodynamic Therapy                  | > CIM 35-100    |
+-----------+---------------------------------------+-----------------+
| 80.3      | > Photosensitive Drugs                | CIM 45-30       |
+-----------+---------------------------------------+-----------------+
| 80.4      | > Hydrophilic Contact Lenses          | CIM 65-1        |
+-----------+---------------------------------------+-----------------+
| 80.5      | > Scleral Shell                       | CIM 65.3        |
+-----------+---------------------------------------+-----------------+
| 80.6      | > Intraocular Photography             | > CIM 35-39     |
+-----------+---------------------------------------+-----------------+
| 80.7      | > Refractive Keratoplasty             | > CIM 35-54     |
+-----------+---------------------------------------+-----------------+
| 80.8      | > Endothelial Cell Photography        | > CIM 50-38     |
+-----------+---------------------------------------+-----------------+
| 80.9      | > Computer Enhanced Perimetry         | CIM 50-49       |
+-----------+---------------------------------------+-----------------+
| 80.10     | Phaco-Emulsification Procedure        | CIM 35-9        |
|           | (Cataract Extraction)                 |                 |
+-----------+---------------------------------------+-----------------+
| 80.11     | > Vitrectomy                          | CIM 35-16       |
+-----------+---------------------------------------+-----------------+
| 80.12     | > Intraocular Lenses (IOLs)           | CIM 65-7        |
+-----------+---------------------------------------+-----------------+
| 90        | Genetics                              | > Reserved - no |
|           |                                       | > text          |
+-----------+---------------------------------------+-----------------+
| 100       | > Gastrointestinal System             | Header          |
+-----------+---------------------------------------+-----------------+
| 100.1     | > Gastric Bypass Surgery for Obesity  | > CIM 35-40     |
+-----------+---------------------------------------+-----------------+
| 100.2     | Endoscopy                             | > CIM 35-59     |
+-----------+---------------------------------------+-----------------+
| 100.3     | > 24-Hour Ambulatory Esophegeal pH    | CIM 35-83       |
|           | > Monitoring                          |                 |
+-----------+---------------------------------------+-----------------+
| 100.4     | > Esophageal Manometry                | CIM 50-25       |
+-----------+---------------------------------------+-----------------+
| 100.5     | > Diagnostic Breath Analyses          | CIM 50-51       |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 100.6     | > Gastric Freezing                    | CIM 35-65       |
+-----------+---------------------------------------+-----------------+
| 100.7     | > Colonic Irrigation                  | CIM 35-1        |
+-----------+---------------------------------------+-----------------+
| 100.8     | > Intestinal By-Pass Surgery          | CIM 35-33       |
+-----------+---------------------------------------+-----------------+
| 100.9     | Implantation of Anti-Gastroesophageal | CIM 35-69       |
|           | Reflux Device                         |                 |
+-----------+---------------------------------------+-----------------+
| 100.10    | Injection Sclerotherapy for           | CIM 35-73       |
|           | Esophageal Variceal Bleeding          |                 |
+-----------+---------------------------------------+-----------------+
| 100.11    | > Gastric Balloon for Treatment of    | > CIM 35-86     |
|           | > Obesity                             |                 |
+-----------+---------------------------------------+-----------------+
| 100.12    | > Gastrophotography                   | CIM 50-9        |
+-----------+---------------------------------------+-----------------+
| 100.13    | > Laproscopic Cholecystectomy         | CIM 35-91       |
+-----------+---------------------------------------+-----------------+
| 110       | Hematology/Immunology/Oncology        | Header          |
+-----------+---------------------------------------+-----------------+
| 110.1     | > Hyperthermia for Treatment of       | > CIM 35-49     |
|           | > Cancer                              |                 |
+-----------+---------------------------------------+-----------------+
| 110.2     | Certain Drugs Distributed by the      | CIM 45-16       |
|           | National Cancer Institute             |                 |
+-----------+---------------------------------------+-----------------+
| 110.3     | > Anti-Inhibitor Coagulant Complex    | > CIM 45-24     |
|           | > (AICC)                              |                 |
+-----------+---------------------------------------+-----------------+
| 110.4     | > Extracorporeal Photopheresis        | CIM 35-88       |
+-----------+---------------------------------------+-----------------+
| 110.5     | > Granulocyte Transfusions            | CIM 45-18       |
+-----------+---------------------------------------+-----------------+
| 110.6     | Scalp Hypothermia During Chemotherapy | CIM 45-21       |
|           | to Prevent Hair Loss                  |                 |
+-----------+---------------------------------------+-----------------+
| 110.7     | Blood Transfusions                    | CIM 45-27       |
+-----------+---------------------------------------+-----------------+
| 110.8     | > Blood Platelet Transfusions         | CIM 35-30       |
+-----------+---------------------------------------+-----------------+
| 10.8.1    | > Stem Cell Transplantation           | CIM 35.30.1     |
+-----------+---------------------------------------+-----------------+
| 110.9     | > Antigens Prepared for Sublingual    | > CIM 45-28     |
|           | > Administration                      |                 |
+-----------+---------------------------------------+-----------------+
| 110.10    | > Intravenous Iron Therapy            | CIM 45-29       |
+-----------+---------------------------------------+-----------------+
| 110.11    | > Food Allergy Testing and Treatment  | CIM 50-53       |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 110.12    | > Challenge Ingestion Food Testing    | CIM 50-22       |
+-----------+---------------------------------------+-----------------+
| 110.13    | > Cytotoxic Food Tests                | > CIM 50-2      |
+-----------+---------------------------------------+-----------------+
| 110.14    | > Apheresis (Therapeutic Pheresis)    | CIM 35-60       |
+-----------+---------------------------------------+-----------------+
| 110.15    | Ultrafiltration, Hemoperfusion and    | CIM 35-38       |
|           | Hemofiltration                        |                 |
+-----------+---------------------------------------+-----------------+
| 110.16    | Nonselective (Random) Transfusions    | CIM 35-71       |
|           | and Living Related Donor Specific     |                 |
|           | Transfusions (DST) in Kidney          |                 |
|           | Transplantation                       |                 |
+-----------+---------------------------------------+-----------------+
| 120       | > Infectious Diseases                 | Reserved - no   |
|           |                                       | text            |
+-----------+---------------------------------------+-----------------+
| 130       | > Mental Health                       | Header          |
+-----------+---------------------------------------+-----------------+
| 130.1     | Inpatient Hospital Stays for the      | CIM 35-22       |
|           | Treatment of Alcoholism               |                 |
+-----------+---------------------------------------+-----------------+
| 130.2     | Outpatient Hospital Services for      | CIM 35-22       |
|           | Treatment of Alcoholism               |                 |
+-----------+---------------------------------------+-----------------+
| 130.3     | Chemical Aversion Therapy for         | CIM 35-23       |
|           | Treatment of Alcoholism               |                 |
+-----------+---------------------------------------+-----------------+
| 130.4     | Electrical Aversion Therapy for       | CIM 35-23.1     |
|           | Treatment of Alcoholism               |                 |
+-----------+---------------------------------------+-----------------+
| 130.5     | Treatment of Alcoholism and Drug      | CIM 35-22.3     |
|           | Abuse in a Freestanding Clinic        |                 |
+-----------+---------------------------------------+-----------------+
| 130.6     | Treatment of Drug Abuse (Chemical     | CIM 35-22.2     |
|           | Dependency)                           |                 |
+-----------+---------------------------------------+-----------------+
| 130.7     | > Withdrawal Treatments for Narcotic  | CIM 35-42       |
|           | > Addictions                          |                 |
+-----------+---------------------------------------+-----------------+
| 130.8     | > Hemodialysis for Treatment of       | > CIM 35-51     |
|           | > Schizophrenia                       |                 |
+-----------+---------------------------------------+-----------------+
| 140       | > Miscellaneous Surgical Procedures   | Header          |
+-----------+---------------------------------------+-----------------+
| 140.1     | Abortion                              | CIM 35-99       |
+-----------+---------------------------------------+-----------------+
| 140.2     | > Breast Reconstruction Following     | CIM 35-47       |
|           | > Mastectomy                          |                 |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 140.3     | > Transsexual Surgery                 | CIM 35-61       |
+-----------+---------------------------------------+-----------------+
| 140.4     | > Plastic Surgery to Correct \"Moon   | CIM 35-12       |
|           | > Face\"                              |                 |
+-----------+---------------------------------------+-----------------+
| 140.5     | > Laser Procedures                    | CIM 35-52       |
+-----------+---------------------------------------+-----------------+
| 150       | > Musculoskeletal System              | Header          |
+-----------+---------------------------------------+-----------------+
| 150.1     | > Manipulation                        | CIM 35-2        |
+-----------+---------------------------------------+-----------------+
| 150.2     | > Osteogenic Stimulator               | CIM 35-48       |
+-----------+---------------------------------------+-----------------+
| 150.3     | > Bone (Mineral) Density Studies      | CIM 50-44       |
+-----------+---------------------------------------+-----------------+
| 150.4     | Neuromuscular Electrical Stimulator   | CIM 35-77       |
|           | (NMES) in the Treatment of Disuse     |                 |
|           | Atrophy                               |                 |
+-----------+---------------------------------------+-----------------+
| 150.5     | > Diathermy Treatment                 | CIM 35-41       |
+-----------+---------------------------------------+-----------------+
| 150.6     | Vitamin B12 Injections to Strengthen  | CIM 45-4        |
|           | Tendons; Ligaments; etc; of the Foot  |                 |
+-----------+---------------------------------------+-----------------+
| 150.7     | Prolotherapy; Joint Sclerotherapy,    | CIM 35-13       |
|           | and Ligamentous Injections with       |                 |
|           | Sclerosing Agents                     |                 |
+-----------+---------------------------------------+-----------------+
| 150.8     | Fluidized Therapy Dry Heat for        | CIM 35-56       |
|           | Certain Musculoskeletal Disorders     |                 |
+-----------+---------------------------------------+-----------------+
| 160       | Nervous System                        | > Header        |
+-----------+---------------------------------------+-----------------+
| 160.1     | > Induced Lesions of Nerve Tracts     | CIM 35-17       |
+-----------+---------------------------------------+-----------------+
| 160.2     | Treatment of Motor Function Disorders | CIM 35-20       |
|           | with Electric Nerve Stimulation       |                 |
+-----------+---------------------------------------+-----------------+
| 160.3     | Assessing Patients Suitability for    | CIM 35-46       |
|           | Electrical Nerve Stimulation          |                 |
+-----------+---------------------------------------+-----------------+
| 160.4     | Steroetactic Cingulotomy as a Means   | CIM 35-84       |
|           | of Psychosurgery                      |                 |
+-----------+---------------------------------------+-----------------+
| 160.5     | > Sterotaxic Depth Electrode          | CIM 50-40       |
|           | > Implantation                        |                 |
+-----------+---------------------------------------+-----------------+
| 160.6     | > Carotid Sinus Nerve Stimulator      | > CIM 65-4      |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 160.7     | > Electrical Nerve Stimulators        | CIM 65-8        |
+-----------+---------------------------------------+-----------------+
| 160.7.1   | Assessing Patients Suitability for    | CIM 35-46       |
|           | Electrical Nerve Stimulation Therapy  |                 |
+-----------+---------------------------------------+-----------------+
| 160.8     | Electroencephalographic Monitoring    | CIM 35-57       |
|           | During Surgical Procedures Involving  |                 |
|           | the Cerebral Vasculature              |                 |
+-----------+---------------------------------------+-----------------+
| 160.9     | Electroencephalographic (EEG)         | CIM 35-57.1     |
|           | Monitoring During Open-Heart Surgery  |                 |
+-----------+---------------------------------------+-----------------+
| 160.10    | > Evoked Response Tests               | > CIM 50-31     |
+-----------+---------------------------------------+-----------------+
| 160.11    | > Osteogenic Stimulation              | CIM 35-48       |
+-----------+---------------------------------------+-----------------+
| 160.12    | Neuromuscular Electrical Stimulation  | CIM 35-77       |
|           | (NMES) in the Treatment of Disuse     |                 |
|           | Atrophy                               |                 |
+-----------+---------------------------------------+-----------------+
| 160.13    | Supplies Used in the Delivery of      | CIM 45-25       |
|           | Transcutaneous Electrical Nerve       |                 |
|           | Stimulation (TENS) and Neuromuscular  |                 |
|           | Electrical Stimulation (NMES)         |                 |
+-----------+---------------------------------------+-----------------+
| 160.14    | > Invasive Intracranial Pressure      | CIM 35-62       |
|           | > Monitoring                          |                 |
+-----------+---------------------------------------+-----------------+
| 160.15    | Electrotherapy for Treatment of       | CIM 35-72       |
|           | Facial Nerve Palsy (Bell's Palsy)     |                 |
+-----------+---------------------------------------+-----------------+
| 160.16    | > Vertebral Axial Decompression       | > CIM 35-97     |
|           | > (VAX-D)                             |                 |
+-----------+---------------------------------------+-----------------+
| 160.17    | L-Dopa                                | > CIM 45-1      |
+-----------+---------------------------------------+-----------------+
| 160.18    | Vagus Nerve Stimulation for Treatment | CIM 60-22       |
|           | of Seizures                           |                 |
+-----------+---------------------------------------+-----------------+
| 160.19    | > Phrenic Nerve Stimulator            | CIM 65-13       |
+-----------+---------------------------------------+-----------------+
| 160.20    | Transfer Factor For Treatment of      | CIM 45-17       |
|           | Multiple Sclerosis                    |                 |
+-----------+---------------------------------------+-----------------+
| 160.21    | > Telephone Transmission of EEGs      | > CIM 50-39     |
+-----------+---------------------------------------+-----------------+
| 160.22    | > Ambulatory EEG Monitoring           | > CIM 50-39.1   |
+-----------+---------------------------------------+-----------------+
| 160.23    | > Current Perception                  | CIM - 50-57.1   |
|           | > Threshold/Sensory Nerve             |                 |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
|           | Conduction Threshold Test (sNCT)      |                 |
+-----------+---------------------------------------+-----------------+
| 160.24    | Deep Brain Stimulation for Essential  | CIM 65-19       |
|           | Tremor and Parkinson's Disease        |                 |
+-----------+---------------------------------------+-----------------+
| 160.25    | > Multiple Electroconvulsive Therapy  | CIM 35-103      |
|           | > (MECT)                              |                 |
+-----------+---------------------------------------+-----------------+
| 170       | Nonphysician Practitioner Services    | Header          |
|           | (PT/OT/SLP/Audiologists/CRNA          |                 |
+-----------+---------------------------------------+-----------------+
| 170.1     | Institutional and Home Care Patient   | CIM 80-1        |
|           | Education Programs                    |                 |
+-----------+---------------------------------------+-----------------+
| 170.2     | > Melodic Intonation Therapy          | CIM 35-67       |
+-----------+---------------------------------------+-----------------+
| 170.3     | Speech Pathology Services for the     | CIM 35-89       |
|           | Treatment of Dysphagia                |                 |
+-----------+---------------------------------------+-----------------+
| 180       | > Nutrition                           | Header          |
+-----------+---------------------------------------+-----------------+
| 180.1     | > Medical Nutrition Therapy           | CIM 80-3        |
+-----------+---------------------------------------+-----------------+
| 180.2     | > Enteral and Parenteral Nutritional  | > CIM 65-10     |
|           | > Therapy                             |                 |
+-----------+---------------------------------------+-----------------+
| 190       | Pathology and Laboratory              | Header          |
+-----------+---------------------------------------+-----------------+
| 190.1     | > Histocompatibility Testing          | CIM 50-23       |
+-----------+---------------------------------------+-----------------+
| 190.2     | > Diagnostic Pap Smears               | CIM 50-20       |
+-----------+---------------------------------------+-----------------+
| 190.3     | > Cytogenetic Studies                 | CIM 50-29       |
+-----------+---------------------------------------+-----------------+
| 190.4     | > Electron Microscope                 | CIM 50-18       |
+-----------+---------------------------------------+-----------------+
| 190.5     | Sweat Test                            | CIM 50-35       |
+-----------+---------------------------------------+-----------------+
| 190.6     | Hair Analysis                         | CIM 50-24       |
+-----------+---------------------------------------+-----------------+
| 190.7     | Human Tumor Stem Cell Drug            | CIM 50-41       |
|           | Sensitivity Assays                    |                 |
+-----------+---------------------------------------+-----------------+
| 190.8     | > Lymphocyte Mitogen Response Assays  | > CIM 50-45     |
+-----------+---------------------------------------+-----------------+
| 190.9     | Serologic Testing for Acquired        | CIM 50-52       |
|           | Immunodeficiency Syndrome (AIDS)      |                 |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 190.10    | > Laboratory Tests                    | CRD Patients    |
+-----------+---------------------------------------+-----------------+
| 190.11    | Home Prothrombin Time INR Monitoring  | CIM 50-56       |
|           | for Anticoagulation Management        |                 |
+-----------+---------------------------------------+-----------------+
| 200       | > Pharmacology                        | > Reserved-no   |
|           |                                       | > text          |
+-----------+---------------------------------------+-----------------+
| 210       | Prevention                            | Header          |
+-----------+---------------------------------------+-----------------+
| 210.1     | > Prostate Cancer Screening Tests     | CIM 50-55       |
+-----------+---------------------------------------+-----------------+
| 210.2     | Screening Pap Smears and Pelvic       | CIM 50-20.1     |
|           | Examinations for Early Detection of   |                 |
|           | Cervical or Vaginal Cance             |                 |
+-----------+---------------------------------------+-----------------+
| 220       | Radiology                             | Header          |
+-----------+---------------------------------------+-----------------+
| 220.1     | Computerized Tomography               | CIM 50-12       |
+-----------+---------------------------------------+-----------------+
| 220.2     | > Magnetic Resonance Imaging          | > CIM 50-13     |
+-----------+---------------------------------------+-----------------+
| 220.3     | > Magnetic Resonance Angiography      | CIM 50-14       |
+-----------+---------------------------------------+-----------------+
| 220.4     | > Mammograms                          | CIM 50-21       |
+-----------+---------------------------------------+-----------------+
| 220.5     | > Ultrasound Diagnostic Procedures    | CIM 50-7        |
+-----------+---------------------------------------+-----------------+
| 220.6     | > Positron Emission Tomography (PET)  | CIM 50-36       |
|           | > Scans                               |                 |
+-----------+---------------------------------------+-----------------+
| 220.7     | Xenon Scan                            | > CIM 50-27     |
+-----------+---------------------------------------+-----------------+
| 220.8     | > Nuclear Radiology Procedure         | > CIM 50-30     |
+-----------+---------------------------------------+-----------------+
| 220.9     | > Digital Subtraction Angiography     | > CIM 50-43     |
+-----------+---------------------------------------+-----------------+
| 220.10    | > Portable Hand-Held X-Ray Instrument | CIM 50-48       |
+-----------+---------------------------------------+-----------------+
| 220.11    | > Thermography                        | > CIM 50-5      |
+-----------+---------------------------------------+-----------------+
| 220.12    | Single Photon Emission Computed       | CIM 50-58       |
|           | Tomograph (SPECT)                     |                 |
+-----------+---------------------------------------+-----------------+
| 220.13    | > Percutaneous Image-Guided Breast    | CIM 50-59       |
|           | > Biopsy                              |                 |
+-----------+---------------------------------------+-----------------+
| 230       | Renal and Genitourinary System, ESRD  | > Header        |
|           | Services                              |                 |
+-----------+---------------------------------------+-----------------+
| 230.1     | Treatment of Kidney Stones            | CIM 35-81       |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 230.2     | > Uroflowmetric Evaluations           | CIM 35-33       |
+-----------+---------------------------------------+-----------------+
| 230.3     | > Sterilization                       | CIM 35-11       |
+-----------+---------------------------------------+-----------------+
| 230.4     | > Diagnosis and Treatment of          | CIM 35-24       |
|           | > Impotence                           |                 |
+-----------+---------------------------------------+-----------------+
| 230.5     | > Gravlee Jet Washer                  | CIM 50-4        |
+-----------+---------------------------------------+-----------------+
| 230.6     | > Vabra Aspirator                     | CIM 50-10       |
+-----------+---------------------------------------+-----------------+
| 230.7     | Water Purification and Softening      | CIM 55-1        |
|           | Systems Used in Conjunction with Home |                 |
|           | Dialysis                              |                 |
+-----------+---------------------------------------+-----------------+
| 230.8     | Non-Implantable Pelvic Flood          | CIM 60-24       |
|           | Electrical Stimulator                 |                 |
+-----------+---------------------------------------+-----------------+
| 230.9     | > Cryosurgery of Prostate             | CIM 35-96       |
+-----------+---------------------------------------+-----------------+
| 230.10    | > Incontinence Control Devices        | > CIM 65-9      |
+-----------+---------------------------------------+-----------------+
| 230.11    | > Diagnostic Pap Smears               | CIM 50-20       |
+-----------+---------------------------------------+-----------------+
| 230.12    | Dimethyl Sulfoxide (DMSO)             | CIM 45-23       |
+-----------+---------------------------------------+-----------------+
| 230.13    | > Peridex CAPD Filter Set             | > CIM 55-2      |
+-----------+---------------------------------------+-----------------+
| 230.14    | > Ultrafiltration Monitor             | CIM 55-3        |
+-----------+---------------------------------------+-----------------+
| 230.15    | > Electrical Continence Aid           | > CIM 65-2      |
+-----------+---------------------------------------+-----------------+
| 230.16    | > Bladder Stimulators (Pacemakers)    | > CIM 65-11     |
+-----------+---------------------------------------+-----------------+
| 230.17    | > Urinary Drainage Bags               | CIM 65-17       |
+-----------+---------------------------------------+-----------------+
| 230.18    | Sacral Nerve Stimulation for Urinary  | CIM 65-18       |
|           | Incontinence                          |                 |
+-----------+---------------------------------------+-----------------+
| 230.19    | Levocarnitine for Use in the          | CIM 45-32       |
|           | Treatment of Carnitine Deficiency in  |                 |
|           | ESRD Patients                         |                 |
+-----------+---------------------------------------+-----------------+
| 240       | > Respiratory System                  | Header          |
+-----------+---------------------------------------+-----------------+
| 240.1     | Lung Volume Reduction Surgery         | CIM 35-93       |
|           | (Reduction Pneumoplasty)              |                 |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 240.2     | Home Use of Oxygen                    | > CIM 60-4      |
+-----------+---------------------------------------+-----------------+
| 240.3     | Heat Treatment, Including the Use of  | CIM 35-3        |
|           | Diathermy and Ultra-Sound for         |                 |
|           | Pulmonary Conditions                  |                 |
+-----------+---------------------------------------+-----------------+
| 240.4     | > Continuous Positive Airway Pressure | > CIM 60-17     |
|           | > (CPAP)                              |                 |
+-----------+---------------------------------------+-----------------+
| 240.5     | > Intrapulmonary Percussive           | CIM 60-21       |
|           | > Ventilator (IPV)                    |                 |
+-----------+---------------------------------------+-----------------+
| 240.6     | > Transvenous (Catheter) Pulmonary    | > CIM 35-55     |
|           | > Embolectomy                         |                 |
+-----------+---------------------------------------+-----------------+
| 240.7     | Postural Drainage Procedures and      | CIM 35-15       |
|           | Pulmonary Exercises                   |                 |
+-----------+---------------------------------------+-----------------+
| 250       | Skin                                  | > Header        |
+-----------+---------------------------------------+-----------------+
| 250.1     | > Treatment of Psoriasis              | CIM 35-66       |
+-----------+---------------------------------------+-----------------+
| 250.2     | Hemorheograph                         | CIM 50-16       |
+-----------+---------------------------------------+-----------------+
| 250.3     | Intravenous Immune Globulin For The   | CIM 45-31       |
|           | Treatment Of Autoimmune Mucutaneous   |                 |
|           | Blistering Diseases                   |                 |
+-----------+---------------------------------------+-----------------+
| 250.4     | > Treatment of Actinic Keratosis      | CIM 25-101      |
+-----------+---------------------------------------+-----------------+
| 260       | Transplantation - Solid Organ         | Header          |
|           | Transplants, Stem Cell                |                 |
|           | Transplantation                       |                 |
+-----------+---------------------------------------+-----------------+
| 260.1     | > Adult Liver Transplantation         | CIM 35-53       |
+-----------+---------------------------------------+-----------------+
| 260.2     | > Pediatric Liver Transplantation     | CIM 35-53.1     |
+-----------+---------------------------------------+-----------------+
| 260.3     | > Pancreas Transplants                | CIM 35-82       |
+-----------+---------------------------------------+-----------------+
| 260.4     | > Lung Transplantation                | To be added     |
+-----------+---------------------------------------+-----------------+
| 260.5     | > Intestinal and Multivisceral        | CIM 35-104      |
|           | > Transplantation                     |                 |
+-----------+---------------------------------------+-----------------+
| 260.6     | Dental Examination Prior to Kidney    | CIM 50-26       |
|           | Transplantation                       |                 |
+-----------+---------------------------------------+-----------------+
| 260.7     | Lymphocyte Immune Globulin,           | CIM 45-22       |
|           | Anti-Thymocyte Globulin (Equine)      |                 |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 260.8     | Reserved                              |                 |
+-----------+---------------------------------------+-----------------+
| 260.9     | > Heart Transplants                   | CIM 35-87       |
+-----------+---------------------------------------+-----------------+
| 270       | Wound Treatment                       | Header          |
+-----------+---------------------------------------+-----------------+
| 270.1     | > Electrostimulation in the Treatment | CIM 35-98       |
|           | > of Wounds                           |                 |
+-----------+---------------------------------------+-----------------+
| 270.2     | Noncontact Normothermic Wound Therapy | CIM 60-25       |
|           | (NNWT)                                |                 |
+-----------+---------------------------------------+-----------------+
| 270.3     | > Platelet-Derived Wound Healing      | CIM 45-26       |
|           | > Formula                             |                 |
+-----------+---------------------------------------+-----------------+
| 270.4     | > Treatment Of Decubitus Ulcers       | CIM 35-31       |
+-----------+---------------------------------------+-----------------+
| 270.5     | > Porcine Skin and Gradient Pressure  | CIM 45-12       |
|           | > Dressings                           |                 |
+-----------+---------------------------------------+-----------------+
| 280       | > Medical and Surgical Supplies       | Header          |
+-----------+---------------------------------------+-----------------+
| 280.1     | > Durable Medical Equipment Reference | > CIM 60-9      |
|           | > List                                |                 |
+-----------+---------------------------------------+-----------------+
| 280.2     | > White Cane for Use by a Blind       | > CIM 60-3      |
|           | > Person                              |                 |
+-----------+---------------------------------------+-----------------+
| 280.3     | > Specially Sized Wheelchairs         | CIM 60-6        |
+-----------+---------------------------------------+-----------------+
| 280.4     | Seat Lift                             | > CIM 60-8      |
+-----------+---------------------------------------+-----------------+
| 280.5     | Safety Roller                         | CIM 60-15       |
+-----------+---------------------------------------+-----------------+
| 280.6     | > Pneumatic Compression Devices       | CIM 60-16       |
+-----------+---------------------------------------+-----------------+
| 280.7     | > Hospital Beds                       | CIM 60-18       |
+-----------+---------------------------------------+-----------------+
| 280.8     | > Air-Fluidized Bed                   | CIM 60-19       |
+-----------+---------------------------------------+-----------------+
| 280.9     | Power Operated Vehicles That May Be   | CIM 60-5        |
|           | Used as Wheelchairs                   |                 |
+-----------+---------------------------------------+-----------------+
| 280.10    | > Prosthetic Shoe                     | CIM 70-3        |
+-----------+---------------------------------------+-----------------+
| 280.11    | > Corset Used as Hernia Support       | CIM 70-1        |
+-----------+---------------------------------------+-----------------+
| 280.12    | > Sykes Hernia Control                | CIM 70-2        |
+-----------+---------------------------------------+-----------------+
| 280.13    | Transcutaneous Electrical Nerve       | CIM 60-20       |
|           | Stimulators (TENS)                    |                 |
+-----------+---------------------------------------+-----------------+

+-----------+---------------------------------------+-----------------+
| **NCD     | > **Title**                           | **CIM Section   |
| Section** |                                       | \#**            |
+===========+=======================================+=================+
| 280.14    | Infusion Pumps                        | > CIM 60-14     |
+-----------+---------------------------------------+-----------------+
| 290       | Nursing Services                      | Header          |
+-----------+---------------------------------------+-----------------+
| 290.1     | > Home Health Visits to a Blind       | CIM 90-1        |
|           | > Diabetic                            |                 |
+-----------+---------------------------------------+-----------------+
| 290.2     | Home Health Nurses\' Visits to        | CIM 90-2        |
|           | Patients Requiring Heparin Injections |                 |
+-----------+---------------------------------------+-----------------+
| 300       | > Diagnostic Tests Not Otherwise      | > Header        |
|           | > Classified                          |                 |
+-----------+---------------------------------------+-----------------+
| 300.1     | > Obsolete or Unreliable Diagnostic   | CIM 50-34       |
|           | > Tests                               |                 |
+-----------+---------------------------------------+-----------------+
| 310       | > Clinical Trials                     | Header          |
+-----------+---------------------------------------+-----------------+
| 310.1     | > Routine Costs in Clinical Trails    | CIM 30-1        |
+-----------+---------------------------------------+-----------------+
